These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 31965842)

  • 1. Probiotics maintain intestinal secretory immunoglobulin A levels in healthy formula-fed infants: a randomised, double-blind, placebo-controlled study.
    Xiao L; Gong C; Ding Y; Ding G; Xu X; Deng C; Ze X; Malard P; Ben X
    Benef Microbes; 2019 Oct; 10(7):729-739. PubMed ID: 31965842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of probiotics on digestibility and immunity in infants: A study protocol for a randomized controlled trial.
    Xiao L; Ding G; Ding Y; Deng C; Ze X; Chen L; Zhang Y; Song L; Yan H; Liu F; Ben X
    Medicine (Baltimore); 2017 Apr; 96(14):e5953. PubMed ID: 28383398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulatory effect of three probiotic strains on infants' gut microbial composition and immunological parameters on a placebo-controlled, double-blind, randomised study.
    De Andrés J; Manzano S; García C; Rodríguez JM; Espinosa-Martos I; Jiménez E
    Benef Microbes; 2018 Jun; 9(4):573-584. PubMed ID: 29726280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bifidobacterium lactis Bb12 enhances intestinal antibody response in formula-fed infants: a randomized, double-blind, controlled trial.
    Holscher HD; Czerkies LA; Cekola P; Litov R; Benbow M; Santema S; Alexander DD; Perez V; Sun S; Saavedra JM; Tappenden KA
    JPEN J Parenter Enteral Nutr; 2012 Jan; 36(1 Suppl):106S-17S. PubMed ID: 22237870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and tolerance of three probiotic strains in healthy infants: a multi-centre randomized, double-blind, placebo-controlled trial.
    Manzano S; De Andrés J; Castro I; Rodríguez JM; Jiménez E; Espinosa-Martos I
    Benef Microbes; 2017 Aug; 8(4):569-578. PubMed ID: 28555502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faecal SIgA secretion in infants fed on pre- or probiotic infant formula.
    Bakker-Zierikzee AM; Tol EA; Kroes H; Alles MS; Kok FJ; Bindels JG
    Pediatr Allergy Immunol; 2006 Mar; 17(2):134-40. PubMed ID: 16618363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial on the impact of early-life intervention with bifidobacteria on the healthy infant fecal microbiota and metabolome.
    Bazanella M; Maier TV; Clavel T; Lagkouvardos I; Lucio M; Maldonado-Gòmez MX; Autran C; Walter J; Bode L; Schmitt-Kopplin P; Haller D
    Am J Clin Nutr; 2017 Nov; 106(5):1274-1286. PubMed ID: 28877893
    [No Abstract]   [Full Text] [Related]  

  • 8. Bifidobacterium longum subsp infantis CECT7210-supplemented formula reduces diarrhea in healthy infants: a randomized controlled trial.
    Escribano J; Ferré N; Gispert-Llaurado M; Luque V; Rubio-Torrents C; Zaragoza-Jordana M; Polanco I; Codoñer FM; Chenoll E; Morera M; Moreno-Muñoz JA; Rivero M; Closa-Monasterolo R
    Pediatr Res; 2018 Jun; 83(6):1120-1128. PubMed ID: 29538368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bifidobacterium bifidum R0071 decreases stress-associated diarrhoea-related symptoms and self-reported stress: a secondary analysis of a randomised trial.
    Culpepper T; Christman MC; Nieves C; Specht GJ; Rowe CC; Spaiser SJ; Ford AL; Dahl WJ; Girard SA; Langkamp-Henken B
    Benef Microbes; 2016 Jun; 7(3):327-36. PubMed ID: 26839075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life.
    Bakker-Zierikzee AM; Alles MS; Knol J; Kok FJ; Tolboom JJ; Bindels JG
    Br J Nutr; 2005 Nov; 94(5):783-90. PubMed ID: 16277782
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Fortmann I; Marißen J; Siller B; Spiegler J; Humberg A; Hanke K; Faust K; Pagel J; Eyvazzadeh L; Brenner K; Roll C; Pirr S; Viemann D; Stavropoulou D; Henneke P; Tröger B; Körner T; Stein A; Derouet C; Zemlin M; Wieg C; Rupp J; Herting E; Göpel W; Härtel C
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32235769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal secretory immunoglobulin A is increased in healthy infants who receive a formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides.
    Scholtens PA; Alliet P; Raes M; Alles MS; Kroes H; Boehm G; Knippels LM; Knol J; Vandenplas Y
    J Nutr; 2008 Jun; 138(6):1141-7. PubMed ID: 18492847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bifidobacterium bifidum R0071 results in a greater proportion of healthy days and a lower percentage of academically stressed students reporting a day of cold/flu: a randomised, double-blind, placebo-controlled study.
    Langkamp-Henken B; Rowe CC; Ford AL; Christman MC; Nieves C; Khouri L; Specht GJ; Girard SA; Spaiser SJ; Dahl WJ
    Br J Nutr; 2015 Feb; 113(3):426-34. PubMed ID: 25604727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fermented formula in pre-term infants: clinical tolerance, gut microbiota, down-regulation of faecal calprotectin and up-regulation of faecal secretory IgA.
    Campeotto F; Suau A; Kapel N; Magne F; Viallon V; Ferraris L; Waligora-Dupriet AJ; Soulaines P; Leroux B; Kalach N; Dupont C; Butel MJ
    Br J Nutr; 2011 Jun; 105(12):1843-51. PubMed ID: 21426607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Beneficial effects of consumption of a dairy product containing two probiotic strains, Lactobacillus coryniformis CECT5711 and Lactobacillus gasseri CECT5714 in healthy children].
    Lara-Villoslada F; Sierra S; Boza J; Xaus J; Olivares M
    Nutr Hosp; 2007; 22(4):496-502. PubMed ID: 17650892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Probiotic Supplementation of Healthy Term Infants with
    Hiraku A; Nakata S; Murata M; Xu C; Mutoh N; Arai S; Odamaki T; Iwabuchi N; Tanaka M; Tsuno T; Nakamura M
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of perinatal probiotic intervention on gut microbiota: double-blind placebo-controlled trials in Finland and Germany.
    Grześkowiak Ł; Grönlund MM; Beckmann C; Salminen S; von Berg A; Isolauri E
    Anaerobe; 2012 Feb; 18(1):7-13. PubMed ID: 21979491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of two probiotic strains of bifidobacteria in premature infants.
    Underwood MA; Kalanetra KM; Bokulich NA; Lewis ZT; Mirmiran M; Tancredi DJ; Mills DA
    J Pediatr; 2013 Dec; 163(6):1585-1591.e9. PubMed ID: 23993139
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Kusumo PD; Bela B; Wibowo H; Munasir Z; Surono IS
    Benef Microbes; 2019 Apr; 10(3):245-252. PubMed ID: 30694099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of stool microbiota compositions, stool alpha1-antitrypsin and calprotectin concentrations, and diarrhoeal morbidity of Indonesian infants fed breast milk or probiotic/prebiotic-supplemented formula.
    Oswari H; Prayitno L; Dwipoerwantoro PG; Firmansyah A; Makrides M; Lawley B; Kuhn-Sherlock B; Cleghorn G; Tannock GW
    J Paediatr Child Health; 2013 Dec; 49(12):1032-9. PubMed ID: 23782263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.